The Project Management Institute Announces Winners of 2020 PMI® Awards
16.11.2020 17:45:00 EET | Business Wire | Press release
On Tuesday, 20 October, Project Management Institute (PMI) announced the winners of the 2020 PMI® Professional Awards during the Virtual Experience Series event, A New World View: Our Global Impact.
Since 1974, the prestigious PMI Professional Awards have honored organizations and individuals whose passion, talent, and expertise have made the greatest contributions to the project management profession or to PMI.
This year’s PMI Research and Academic Award winners have also been selected. These awards recognize those who have made sustained or significant contributions through teaching, research, or literature.
For more information on the award programs: https://www.pmi.org/about/awards.
PMI® Professional Awards:
PMI Project of the Year – This award recognizes the large and complex project that best delivers superior performance of project management practices, superior organizational results, and positive impacts on society with a project budget of more than US$100 million.
- Winner: The Trans Anatolian Natural Gas Pipeline (TANAP) Project, TANAP Natural Gas Transmission Company (Ankara, Turkey)
- Finalist: Revitalisation de la Tour de Montréal – Montréal Tower Revitalization Project, Parc Olympique (Montréal, Québec, Canada)
- Finalist: Fort McMurray West 500 kV Transmission Project, ATCO (Edmonton, Alberta, Canada)
PMO OF THE YEAR® Award– This award honors a Project Management Office (PMO) that has added value to its organization through its support of successful strategic initiatives and demonstrated superior organizational project management capabilities. It also recognizes a PMO that has established a vision for value delivery and has had a positive and clear impact on business results.
- Winner: DC Water – IT Project Management Office : IT Project Management Office – Making I.T. Happen, (Washington, D.C., U.S.)
- Finalist: Emaar Properties PJSC – Group Operations: Emaar Properties - Group Operations: Strategic Project Management Office(Dubai, United Arab Emirates)
- Finalist: Kern Health Systems: Kern Health Systems Enterprise Project Management Office(Bakersfield, California, U.S.)
PMI Project Excellence Award – This award recognizes complex projects that best deliver superior performance of project management practices, superior organizational results, and positive impacts on society with a project budget of less than US$100 million.
- Asia Pacific Region: PROJECT RURAL MPOWERMENT, Mobitel (Pvt) Ltd (Colombo, Sri Lanka)
- Europe, Middle East, Africa Region: Shaybah Airport Runway Upgrade Project, Saudi Aramco – Oil Facilities Projects Department (Dhahran, Saudi Arabia)
- North America Region: Data-Center Co-Location Project, Adventist Health/ Highmark Solutions (Roseville, California, USA)
PMI Fellow Award – This is the highest and most prestigious individual award presented by Project Management Institute for service to the organization and profession.
- Marge Combe, PMI Fellow
- Dr. Prasad S. Kodukula, PMP, PgMP, PMI Fellow
PMI Eric Jenett Project Management Excellence Award – This award recognizes and honors an individual who has made an outstanding contribution(s) to the project management profession or its practice through leadership, technical project management, and strategic and business management acumen.
- Vanita Ahuja, PhD, PgMP, MRICS
- Dr. Krishna Kumar T I PhD, CDAI
- Kenneth Bainey MBA, PMP
PMI Young Professional Award – This award recognizes and honors young professionals who have made a significant impact in advancing project management within an organization, advancing the knowledge and understanding of the practice of project management, and demonstrating an understanding of PMI standards, practices and ethics.
- Nguyen Si Trieu Chau, LIMC, PfMP, PgMP, PMP, PMI-ACP, PMI-RMP, PMI-SP, IPMO-E, PMO-CP
- Lt. Dimitrios Zaires Exec. MSc, MBA, CMILT, PMI-RMP
- Roman Reznikov
- Dr. Ritu Ahuja, PMI-ACP, MRICS
PMI® Research and Academic Award Winners:
PMI Research Achievement Award – This award recognizes and honors an individual or group of individuals whose work has significantly advanced the concepts, knowledge, and practices of project management through a published body of academic research.
- Professor Monique Aubry, PhD, MPM
PMI Linn Stuckenbruck Teaching Excellence Award – This award recognizes and honors an individual faculty member for excellence in teaching project management, and for their strong commitment to improving and enhancing project management curricula in higher education.
- Callum Robert Kidd (University of Manchester)
PMI Project Management Journal® Paper of the Year Award – This award recognizes the best paper published in the Project Management Journal in the previous year.
- “How Digital Information Transforms Project Delivery Models” by Professor Jennifer Whyte
PMI David I. Cleland Project Management Literature Award – This award recognizes the author(s) of a published book that significantly advances project management knowledge, concepts, and practice.
- “Project Management: A Benefit Realisation Approach” by Professor Ofer Zwikael and John R Smyrk
Find the list of PMI award winners: https://www.pmi.org/about/awards/winners
About Project Management Institute (PMI)
Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Through global advocacy, collaboration, education and research, we work to prepare more than three million professionals around the world for The Project Economy: the coming economy in which work, and individuals, are organized around projects, products, programs and value streams. Now 50 years in the making, we work in nearly every country around the world to advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com® interactive website creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org, www.projectmanagement.com, www.facebook.com/PMInstitute and on Twitter @PMInstitute
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201116005763/en/
Contact information
Media:
Drew Pradeep
Tel: 610-416-6023
Drew.Pradeep@pmi.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 10:00:00 EEST | Press release
Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discovery teams to accelerate decision-making, streamline workflows, and advance programs more efficiently from hit identification through lead optimization. "Drug discovery increasingly requires seamless integration between chemistry and biology," said Michael Dabrowski, Chief Executive Officer of Pelago Bioscience. "By bringing RG Discovery
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 09:10:00 EEST | Press release
LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across systems, identify root causes, and execute actions within governed guardrails. iRun combines AI agents and human expertise to shift opera
Azafaros to Present at BIO International Convention 202615.6.2026 08:00:00 EEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 07:05:00 EEST | Press release
Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integration, Black Recon allows crews to launch, operate, recover, and recharge up to three unmanned aerial systems without leaving their platform, reducing risk and accelerating decision-making. “Black Recon
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
